Literature DB >> 28188516

New Consensus Definitions for Sepsis and Septic Shock: Implications for Treatment Strategies and Drug Development?

Michael Berry1, Brijesh V Patel2,3, Stephen J Brett3,4.   

Abstract

Sepsis continues to escape a precise diagnostic definition. The most recent consensus definition, termed Sepsis-3, highlights the importance of the maladaptive and potentially life-threatening host response to infection. After briefly reviewing the history and epidemiology of sepsis, we go on to describe some of the challenges encountered when classifying such a heterogenous disease state. In the context of these new definitions for sepsis and septic shock, we explore current and potentially novel therapies, and conclude by mentioning some of the controversies of this most recent framework.

Entities:  

Mesh:

Year:  2017        PMID: 28188516     DOI: 10.1007/s40265-017-0698-0

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  48 in total

Review 1.  A rational approach to fluid therapy in sepsis.

Authors:  P Marik; R Bellomo
Journal:  Br J Anaesth       Date:  2015-10-27       Impact factor: 9.166

2.  Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock.

Authors:  Anand Kumar; Daniel Roberts; Kenneth E Wood; Bruce Light; Joseph E Parrillo; Satendra Sharma; Robert Suppes; Daniel Feinstein; Sergio Zanotti; Leo Taiberg; David Gurka; Aseem Kumar; Mary Cheang
Journal:  Crit Care Med       Date:  2006-06       Impact factor: 7.598

3.  Albumin replacement in patients with severe sepsis or septic shock.

Authors:  Pietro Caironi; Gianni Tognoni; Serge Masson; Roberto Fumagalli; Antonio Pesenti; Marilena Romero; Caterina Fanizza; Luisa Caspani; Stefano Faenza; Giacomo Grasselli; Gaetano Iapichino; Massimo Antonelli; Vieri Parrini; Gilberto Fiore; Roberto Latini; Luciano Gattinoni
Journal:  N Engl J Med       Date:  2014-03-18       Impact factor: 91.245

4.  New Sepsis Criteria: A Change We Should Not Make.

Authors:  Steven Q Simpson
Journal:  Chest       Date:  2016-02-27       Impact factor: 9.410

5.  Dopamine versus norepinephrine in the treatment of septic shock: a meta-analysis*.

Authors:  Daniel De Backer; Cesar Aldecoa; Hassane Njimi; Jean-Louis Vincent
Journal:  Crit Care Med       Date:  2012-03       Impact factor: 7.598

Review 6.  Vasopressors for hypotensive shock.

Authors:  Gunnar Gamper; Christof Havel; Jasmin Arrich; Heidrun Losert; Nathan Leon Pace; Marcus Müllner; Harald Herkner
Journal:  Cochrane Database Syst Rev       Date:  2016-02-15

7.  Design of clinical trials in sepsis: problems and pitfalls.

Authors:  R G Finch
Journal:  J Antimicrob Chemother       Date:  1998-01       Impact factor: 5.790

8.  New approaches to sepsis: molecular diagnostics and biomarkers.

Authors:  Konrad Reinhart; Michael Bauer; Niels C Riedemann; Christiane S Hartog
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

Review 9.  Therapeutic interventions in sepsis: current and anticipated pharmacological agents.

Authors:  Prashant Shukla; G Madhava Rao; Gitu Pandey; Shweta Sharma; Naresh Mittapelly; Ranjita Shegokar; Prabhat Ranjan Mishra
Journal:  Br J Pharmacol       Date:  2014-09-05       Impact factor: 8.739

Review 10.  Vasopressors for the Treatment of Septic Shock: Systematic Review and Meta-Analysis.

Authors:  Tomer Avni; Adi Lador; Shaul Lev; Leonard Leibovici; Mical Paul; Alon Grossman
Journal:  PLoS One       Date:  2015-08-03       Impact factor: 3.240

View more
  1 in total

1.  Sepsis criteria versus clinical diagnosis of sepsis in burn patients: A validation of current sepsis scores.

Authors:  Jinhui Yan; William F Hill; Sarah Rehou; Ruxandra Pinto; Shahriar Shahrokhi; Marc G Jeschke
Journal:  Surgery       Date:  2018-07-23       Impact factor: 3.982

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.